Lung cancer surgery in Denmark
- PMID: 36245602
- PMCID: PMC9562496
- DOI: 10.21037/jtd-22-371
Lung cancer surgery in Denmark
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-22-371/coif). The series “Thoracic Surgery Worldwide” was commissioned by the editorial office without any funding or sponsorship. TDC has in the last 36 month been on the speaker bureaus for AstraZeneca and Bristol-Myers Squibb and has been in an Advisory Board for Sanofi and AstrZeneca. RHP serves as an unpaid editorial board member of Journal of Thoracic Disease and he reports speaker fee from Medtronic and AMBU and advisory board membership in AstraZeneca, MSD and Roche. The authors have no other conflicts of interest to declare.
Figures
References
-
- Batchelor TJP, Rasburn NJ, Abdelnour-Berchtold E, et al. Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS). Eur J Cardiothorac Surg 2019;55:91-115. 10.1093/ejcts/ezy301 - DOI - PubMed
-
- Sundhedsstyrelsen Danish health authority . Available online: https://www.sst.dk/-/media/Udgivelser/2018/Lungekraeft/Pakkeforl%C3%B8b-...
-
- Bekendtgørelse om maksimale ventetider ved behandling af kræft og visse tilstande ved iskæmiske hjertesygdomme. Available online: https://www.retsinformation.dk/eli/lta/2015/584
-
- Dansk Lunge Cancer Gruppe . Available online: https://www.lungecancer.dk/referenceprogram/
Publication types
LinkOut - more resources
Full Text Sources